Among patients with macroprolactinomas, the presence of both low PRL levels and adenoma disappearance provided 67 % assurance for permanent or very long-standing remission, compared with only 22 % assurance for patients with a visible remnant on MRI [42]. The gene discussed is PRL; the disease is adenoma.